Gruppo Oncologico del Nord-Ovest

🇮🇹Italy
Ownership
Private
Established
1987-01-01
Employees
-
Market Cap
-
Website
http://gonogroup.org/

Targeting the Tumor Microenvironment in R/M SCCHN

First Posted Date
2019-02-18
Last Posted Date
2020-03-03
Lead Sponsor
Gruppo Oncologico del Nord-Ovest
Target Recruit Count
71
Registration Number
NCT03844763
Locations
🇮🇹

AO Santa Croce e Carle di Cuneo, Cuneo, Italia/cuneo, Italy

🇮🇹

Azienda Ospedaliera S. Croce E Carle Di Cuneo - Cuneo (Cn) Oncologia Medica, Cuneo, Italy

FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients

First Posted Date
2018-10-26
Last Posted Date
2023-10-12
Lead Sponsor
Gruppo Oncologico del Nord-Ovest
Target Recruit Count
218
Registration Number
NCT03721653
Locations
🇮🇹

Francesca Vannini, Pisa, Italia, Italy

First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTS

First Posted Date
2017-07-27
Last Posted Date
2023-01-05
Lead Sponsor
Gruppo Oncologico del Nord-Ovest
Target Recruit Count
435
Registration Number
NCT03231722
Locations
🇮🇹

Fondazione IRCCS Istituto Oncologico Veneto, Padova, Italy

🇮🇹

A.O. Universitaria Pisana - Pisa (Pi) Oncologia Medica, Pisa, Italy

🇮🇹

Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy

and more 1 locations

Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly Patients

First Posted Date
2016-09-16
Last Posted Date
2020-05-12
Lead Sponsor
Gruppo Oncologico del Nord-Ovest
Target Recruit Count
180
Registration Number
NCT02904031
Locations
🇮🇹

Istituto Oncologico Veneto IRCCS, Padua, Italy

Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRC

First Posted Date
2015-01-15
Last Posted Date
2020-02-05
Lead Sponsor
Gruppo Oncologico del Nord-Ovest
Target Recruit Count
654
Registration Number
NCT02339116
Locations
🇮🇹

Polo Oncologico - AOUP, Pisa, PI, Italy

Induction Chemoterapy With Folfoxiri Plus Cetuxumab in Unresectable Colorectal Cancer Patient

First Posted Date
2014-11-20
Last Posted Date
2015-03-12
Lead Sponsor
Gruppo Oncologico del Nord-Ovest
Target Recruit Count
143
Registration Number
NCT02295930
Locations
🇮🇹

A.O.Universitaria Policlinico S.Orsola-Malpighi Di Bologna (Oncologia Medica), Bologna, Italy

🇮🇹

Istituto Ospedaliero Fondazione Poliambulanza Di Brescia - Brescia (Bs) Oncologia Medica, Brescia, Italy

🇮🇹

Ospedale Civile Ss. Antonio E Biagio Di Alessandria - Alessandria (Al) Oncologia Medica, Alessandria, Italy

and more 19 locations

Cetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET).

First Posted Date
2014-11-20
Last Posted Date
2018-02-15
Lead Sponsor
Gruppo Oncologico del Nord-Ovest
Target Recruit Count
27
Registration Number
NCT02296203
Locations
🇮🇹

Azienda Ospedaliero Universitaria Di Parma - U.O.Oncologia Medica, Parma, Italy

🇮🇹

A.O. Universitaria S.Maria Della Misericordia Di Udine, Udine, Italy

🇮🇹

Azienda Policlinico Umberto I - Oncologia Medica, Roma, Italy

and more 6 locations

FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer

Phase 2
Completed
Conditions
Interventions
First Posted Date
2011-05-24
Last Posted Date
2015-03-11
Lead Sponsor
Gruppo Oncologico del Nord-Ovest
Target Recruit Count
37
Registration Number
NCT01358812
Locations
🇮🇹

P.O. Zona Aretina - Ospedale S. Donato Di Arezzo, Arezzo, Italy

🇮🇹

IRCCS Ospedale San Raffaele, Milano, Italy

🇮🇹

Istituto Nazionale Per La Ricerca Sul Cancro, Genova, Italy

and more 7 locations

FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-10-13
Last Posted Date
2015-03-11
Lead Sponsor
Gruppo Oncologico del Nord-Ovest
Target Recruit Count
244
Registration Number
NCT01219920
Locations
🇮🇹

A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di Ancona - Ancona (An) Oncologia Medica, Ancona, Italy

🇮🇹

Ospedale Civile Ss. Antonio E Biagio Di Alessandria - Alessandria (Al) Oncologia Medica, Alessandria, Italy

🇮🇹

Ausl Della Valle D' Aosta (Ao) - Aosta (Ao) Oncologia Medica, Aosta, Italy

and more 45 locations

First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer

First Posted Date
2010-07-15
Last Posted Date
2015-03-11
Lead Sponsor
Gruppo Oncologico del Nord-Ovest
Target Recruit Count
57
Registration Number
NCT01163396
© Copyright 2024. All Rights Reserved by MedPath